Global Radiodermatitis Market was valued at USD 362.5 million in 2019 which is expected to reach USD 474.22 million by 2030 at a CAGR 3.5%
Radiodermatitis is also refereed as X-ray dermatitis, radiation dermatitis, and radiation injury. It is side effect of external beam ionizing radiation. Radiotherapy is used for the cancer treatment or other diseases are the main cause of radiothermatitis.
Rise in prevalence of cancer is the key driving factor which is expected to boost the global radiodermatitis market growth. For Instance, in 2019, according to American Cancer Society around 1,762,450 estimated cancer cases diagnosed and around 606,880 cancer deaths in United State. Furthermore, increase in research and developments of new therapies for treatment of radiodermatitis will have the positive impact in global radiodermatitis market growth. In addition to that, investing in creating awareness regarding radiation included skin damage is expected to fuel the global radiodermatitis market growth.
However, high cost of dressings such as honey-impregnated dressing and silicone dressing is the restraining factor which is expected to hamper the global radiodermatitis market growth.
Global Radiodermatitis Market is segmented into product such as Topical (Corticosteroids, Hydrophilic Creams, Antibiotics, and Others), Oral, and Dressings (No Sting barrier film, Silicone Coated dressings, Honey impregnated gauze, and Others). Further, Global Radiodermatitis Market is segmented into distribution channel such as Hospital Pharmacy, Retail Pharmacy, and Others.
Also, Global Radiodermatitis Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Jay Pharma, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc, Molnlycke Health Care, Intermed Pharmaceuticals, DermaSciences Inc, ConvaTec Group PLC, BMG Pharma S.r.l, and Acelity, Inc. (3M)
Market Taxonomy
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5.2 Global Radiodermatitis Market Share Analysis, By Product
5.3 Global Radiodermatitis Market Size and Forecast, By Product
5.3.1 Topical
5.3.1.1 Corticosteroids
5.3.1.2Hydrophillic Creams
5.3.1.3Antibiotics
5.3.1.4Others
5.3.2 Oral
5.3.3Dressings
5.3.3.1No String barrier film
5.3.3.2Silicone Coated dressings
5.3.3.3Honey impregnated gauze
5.3.3.4Others
6.1 Y-o-Y Growth Comparison, By Distribution Channel
6.2 Global Radiodermatitis Market Share Analysis, By Distribution Channel
6.3 Global Radiodermatitis Market Size and Forecast, By Distribution Channel
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Others
7.1 Global Radiodermatitis Market Share Analysis, By Region
7.2 Global Radiodermatitis Market Share Analysis, By Region
7.3 Global Radiodermatitis Market Size and Forecast, By Region
8.1 Introduction
8.2 North America Radiodermatitis Market Share Analysis, By Product
8.3 North America Radiodermatitis Market Size and Forecast, By Distribution Channel
8.4 North America Radiodermatitis Market Size and Forecast, By Country
8.4.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9.1 Introduction
9.2 Europe Radiodermatitis Market Share Analysis, By Product
9.3 Europe Radiodermatitis Market Size and Forecast, By Distribution Channel
9.4 Europe Radiodermatitis Market Size and Forecast, By Country
9.4.1 Germany 9.4.2 France 9.4.3 UK
9.4.4. Rest of Europe
10.1 Introduction
10.2 Asia Pacific Radiodermatitis Market Share Analysis, By Product
10.3 Asia Pacific Radiodermatitis Market Size and Forecast, By Distribution Channel
10.4 Asia Pacific Radiodermatitis Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11.1 Introduction
11.2 Latin America Radiodermatitis Market Share Analysis, By Product
11.3 Latin America Radiodermatitis Market Size and Forecast, By Distribution Channel
11.4 Latin America Radiodermatitis Market Size and Forecast, By Country
12.1 Introduction
12.2 Middle East Radiodermatitis Market Share Analysis, By Product
12.3 Middle East Radiodermatitis Market Size and Forecast, By Distribution Channel
12.4 Middle East Radiodermatitis Market Size and Forecast, By Country
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Smith & Nephew Plc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Stratpharma AG
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Kannalife, Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Molnlycke Health Care
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Intermed Pharmaceuticals
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 DermaSciences Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 ConvaTec Group PLC
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 BMG Pharma S.r.I
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Acelity, Inc. (3M)
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
